Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Claire Duggal

Plastic and Reconstructive Surgery Annapolis, MD Medical Doctor

NPI 1164682746 CMS profile 567059

621 Ridgely Ave 401, Annapolis, MD 21401

Open in the dashboard

General payments

$3,312

113 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Claire Duggal of Annapolis, MD is reported in the CMS Open Payments database as having received $3,312 across 113 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Plastic and Reconstructive Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $515 23
2024 General $389 19
2023 General $331 20
2022 General $934 22
2021 General $348 15
2020 General $310 9
2019 General $485 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Claire Duggal
  • Plastic and Reconstructive Surgery median
  • Middle half of Plastic and Reconstructive Surgery
  • National median

In program year 2025, general payments to Claire Duggal were reported at $515. Among 2,070 Plastic and Reconstructive Surgery profiles paid that year, the median was $442 and the middle half received between $150 and $1,242.

Show as a table
Year Claire Duggal Plastic and Reconstructive Surgery median Middle half National median
2019 $485 $335 $121–$1,264 $163
2020 $310 $162 $57–$417 $114
2021 $348 $245 $89–$735 $132
2022 $934 $325 $120–$932 $149
2023 $331 $343 $129–$999 $160
2024 $389 $390 $141–$1,085 $164
2025 $515 $442 $150–$1,242 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sientra, Inc. $1,083 20 payments
  2. Galderma Laboratories, L.P. $461 22 payments
  3. Surgical Innovation Associates, Inc. $402 1 payment
  4. Revance Therapeutics, Inc. $386 19 payments
  5. Allergan Inc. $292 19 payments
  6. AbbVie, Inc. $288 23 payments
  7. Motiva USA, LLC $187 4 payments
  8. Merz North America, Inc. $152 2 payments
  9. Pacira Pharmaceuticals Incorporated $40 2 payments
  10. Mentor Worldwide LLC $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,910 112 payments
  2. Long term medical supply or device loan $402 1 payment
Products named General payments · program years 2019–2025
  1. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $1,083 20 payments
  2. DuraSorb Monofilament Mesh $402 1 payment
  3. DAXXIFY $386 19 payments
  4. Motiva Implant Matrix $187 4 payments
  5. NATRELLE SALINE-FILLED BREAST IMPLANTS $103 1 payment
  6. BOTOX $75 10 payments
  7. DYSPORT $69 5 payments
  8. DYSPORT $41 2 payments
  9. Exparel $40 2 payments
  10. MENTOR MemoryGel Resterilizable Gel Sizer $21 1 payment
  11. Other $18 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

113 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic and Reconstructive Surgery in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record